The Patent Finder

AIKO Biotechnology

Also on record
Records under this name other than patents AIKO Biotechnology holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to AIKO Biotechnology

PatentTitleStatus Expires Confidence
US 9,061,024Combination analgesic employing opioid agonist and neutral antagonist
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,883,817Combination analgesic employing opioid and neutral antagonist
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,748,448Combination analgesic employing opioid agonist and neutral antagonist
Formerly held
Lapsed on the fee record
Ended Jun 10, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 10, 2026From the USPTO record
US 6,713,488Neutral antagonists and use thereof in treating drug abuse
Formerly held
Term ended
Term ended Mar 15, 2021 · From the USPTO record
Term endedTerm ended Mar 15, 2021From the USPTO record
US 6,270,979Methods for anti-addictive narcotic analgesic treatments
Formerly held
Lapsed on the fee record
Ended Aug 7, 2009 · From the USPTO record
Lapsed on the fee recordEnded Aug 7, 2009From the USPTO record
US 5,882,944Methods for G protein coupled receptor activity screening
Formerly held
Term ended
Term ended no later than Mar 16, 2019 · Low confidence
Term endedTerm ended no later than Mar 16, 2019Low confidence
US 6,007,986Methods for anti-addictive narcotic analgesic activity screening
Formerly held
Term ended
Term ended no later than Dec 28, 2019 · Low confidence
Term endedTerm ended no later than Dec 28, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited